Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 8088786 was granted and assigned to Orexigen Therapeutics on January, 2012 by the United States Patent and Trademark Office. | 8088786 | January 3, 2012 | |||||||
Patent 7462626 was granted and assigned to Orexigen Therapeutics on December, 2008 by the United States Patent and Trademark Office. | 7462626 | December 9, 2008 | |||||||
Patent 8969371 was granted and assigned to Orexigen Therapeutics on March, 2015 by the United States Patent and Trademark Office. | 8969371 | March 3, 2015 | |||||||
Patent 9801875 was granted and assigned to Orexigen Therapeutics on October, 2017 by the United States Patent and Trademark Office. | 9801875 | October 31, 2017 | |||||||
Patent 8916195 was granted and assigned to Orexigen Therapeutics on December, 2014 by the United States Patent and Trademark Office. | 8916195 | December 23, 2014 | |||||||
Patent 8722085 was granted and assigned to Orexigen Therapeutics on May, 2014 by the United States Patent and Trademark Office. | 8722085 | May 13, 2014 | |||||||
Patent 9457005 was granted and assigned to Orexigen Therapeutics on October, 2016 by the United States Patent and Trademark Office. | 9457005 | October 4, 2016 | |||||||
Patent 9633575 was granted and assigned to Orexigen Therapeutics on April, 2017 by the United States Patent and Trademark Office. | 9633575 | April 25, 2017 | |||||||
Patent 9248123 was granted and assigned to Orexigen Therapeutics on February, 2016 by the United States Patent and Trademark Office. | 9248123 | February 2, 2016 | |||||||
Patent 9107837 was granted and assigned to Orexigen Therapeutics on August, 2015 by the United States Patent and Trademark Office. | 9107837 | August 18, 2015 | |||||||
Patent 9119850 was granted and assigned to Orexigen Therapeutics on September, 2015 by the United States Patent and Trademark Office. | 9119850 | September 1, 2015 | |||||||
Patent 9125868 was granted and assigned to Orexigen Therapeutics on September, 2015 by the United States Patent and Trademark Office. | 9125868 | September 8, 2015 | |||||||
Patent 7425571 was granted and assigned to Orexigen Therapeutics on September, 2008 by the United States Patent and Trademark Office. | 7425571 | September 16, 2008 | |||||||
Patent 7375111 was granted and assigned to Orexigen Therapeutics on May, 2008 by the United States Patent and Trademark Office. | 7375111 | May 20, 2008 | |||||||
8815889 | August 26, 2014 | ||||||||
Patent 8318788 was granted and assigned to Orexigen Therapeutics on November, 2012 by the United States Patent and Trademark Office. | 8318788 | November 27, 2012 |